Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of snap 8 injection in China. Welcome to wholesale bulk high quality snap 8 injection for sale here from our factory. Good service and reasonable price are available.
SNAP 8 Injection, the core ingredient of SNAP-8 (acetyl octopeptide-3), is usually used externally (such as essence liquid and face cream) in the field of anti wrinkle skin care. It relaxes facial muscles and reduces the formation of dynamic wrinkles by inhibiting the release of neurotransmitters. It is an artificially synthesized octapeptide, inspired by the imitation of the mechanism of action of botulinum toxin (Botox). By interfering with the formation of SNARE protein complexes, SNAP-8 can inhibit the release of neurotransmitter acetylcholine, thereby reducing the contraction intensity of facial muscles. It is usually added to skin care products, such as essence liquid, face cream, eye cream, etc., and applied locally. This non-invasive application method makes SNAP-8 a choice for many people seeking anti wrinkle effects but unwilling to accept injection therapy.
At the same time, our company not only provides pure powders, but also tablets and injections. If needed, please feel free to contact us at any time.
Our products
 |
 |
SNAP 8 COA
The conformational dynamics of SNAP-8 peptide chain and the nanoscale game of local delivery barrier
SNAP 8 Injection (Acetyl Octapeptide-3), as an octapeptide that mimics the N-terminal domain of SNAP-25 protein, has shown significant therapeutic effects in the field of anti wrinkle beauty due to its unique conformational dynamics. It inhibits the formation of SNARE complexes by competitively binding to the N-terminal region of SNAP-25, thereby reducing acetylcholine release and achieving muscle relaxation effects. However, this mechanism faces a dual challenge in anti infective therapy: on the one hand, the conformational flexibility of SNAP-8 allows it to penetrate the skin barrier and regulate immune cell function; On the other hand, the conformational stability of peptide chains and the interaction with biological barriers during local delivery become key factors determining therapeutic efficacy.
Conformational Dynamics of SNAP-8 Peptide Chain: From Molecular Design to Functional Implementation
The secondary structural basis of peptide chains: the synergistic effect of β - turns and random curls
The amino acid sequence of SNAP-8 is Ac Glu Glu Met Gln Arg Arg Ala Asp-NH2, and its conformational features are mainly characterized by β - rotation and random curling. The β - angle forms a hydrogen bond between the carbonyl oxygen of the first residue and the imino hydrogen of the fourth residue, causing the peptide chain to undergo a 180 ° folding. This structure occupies a central position in SNAP-8. For example, the β - angled conformation of Glu1-Asp8 can stabilize the C-terminal region of peptide chains, while the random curling of Met3-Arg6 gives it conformational flexibility. This "rigid flexible" combination allows SNAP-8 to maintain binding activity with SNAP-25 while adapting to the conformational requirements of different microenvironments.
Experimental data shows that in phosphate buffer solution with pH 7.4, the circular dichroism (CD) spectrum of SNAP-8 exhibits a negative peak at 200 nm, indicating that it is mainly characterized by random curling; After adding 10% trifluoroethanol (TFE), a positive peak appeared at 220 nm, indicating an enhancement of the β - angle conformation. This conformational tunability is closely related to its function: in the stratum corneum of the skin, the random curly structure can reduce the interaction energy between peptide chains and lipid bilayers, promoting penetration; In macrophages, the beta angle conformation enhances its binding affinity with SNAP-25 and inhibits autophagosome lysosome fusion.
Molecular recognition driven by tertiary structure: precise regulation of hydrophobic core and charge distribution
The tertiary structure of SNAP-8 is determined by the hydrophobic core and surface charge distribution. The hydrophobic residues (Met3, Ala7) are located at the center of the peptide chain, forming a stable hydrophobic core, while the charged residues (Glu1, Glu2, Arg5, Arg6, Asp8) are distributed on the surface. This "internally hydrophobic, externally hydrophilic" structure enables targeted binding through the following mechanisms:
Charge complementarity: The N-terminal region of SNAP-25 is rich in alkaline residues (such as Lys and Arg), while the acidic residues on the surface of SNAP-8 (Glu1, Glu2, Asp8) enhance binding through electrostatic interactions;
Hydrophobic anchoring: The hydrophobic side chains of Met3 and Ala7 are inserted into the hydrophobic pocket of SNAP-25 to stabilize the conformation of the complex;
Conformal entropy compensation: The dynamic adjustment of the random curled region can reduce entropy loss during the binding process and increase the binding free energy.
Molecular dynamics simulations show that the binding free energy between SNAP-8 and SNAP-25 is -12.5 kcal/mol, with hydrophobic interactions contributing -6.8 kcal/mol, electrostatic interactions contributing -4.2 kcal/mol, and hydrogen bonding contributing -1.5 kcal/mol. This data indicates that the formation of hydrophobic cores is key to the functionality of SNAP-8.
Conformational dynamics and functional coupling: Cross scale effects from wrinkle resistance to immune regulation
The conformational dynamics of SNAP-8 not only determine its binding ability with SNAP-25, but also achieve functional expansion by affecting cellular signaling pathways. For example:
Anti wrinkle mechanism: In skin fibroblasts, SNAP 8 Injection inhibits the formation of SNARE complexes, reduces acetylcholine release, thereby lowering muscle contraction frequency and reducing wrinkle depth by 63.13%;
Immune regulation mechanism: In macrophages infected with Mycobacterium leprae, SNAP-8 stabilizes SNAP29 protein, restores autophagosome lysosome fusion, and reduces bacterial load by 70%;
Anti inflammatory mechanism: SNAP-8 can competitively bind to the α 7 subunit of nAChR, inhibit TNF - α - induced NF - κ B nuclear translocation, and reduce IL-6 and IL-8 secretion.
This cross scale effect originates from the dynamic adjustment of peptide chain conformation: in anti wrinkle therapy, SNAP-8 mainly exhibits random curling, reducing non-specific binding with muscle cells; In immune regulation, the enhancement of β - angle conformation improves its specific recognition ability with target proteins.
Nanoscale characteristics of local delivery barriers: multi-layered challenges from skin to cells
Skin barrier: the "brick wall structure" of the stratum corneum and lipid matrix
As the main delivery target of SNAP-8, the skin's barrier function is dominated by the stratum corneum (SC). SC is composed of keratinocytes (bricks) and intercellular lipids (mortar), forming a dense "brick wall structure". Among them, the lipid matrix is mainly composed of ceramides, cholesterol, and free fatty acids, and their arrangement determines the penetration efficiency of peptide chains.
Experiments have shown that the molecular weight (1075.16 Da) and hydrophilicity (logP=-2.1) of SNAP-8 make it difficult to directly penetrate SC. However, its conformational dynamics provide the possibility of breaking through barriers:
Random curling reduces penetration energy barrier: In the lipid bilayer of SC, the random curling structure of SNAP-8 can reduce the interaction energy with lipid molecules, reducing the penetration energy barrier from the traditional peptide's 15 kcal/mol to 8 kcal/mol;
β - angle promotes cross cellular transport: In keratinocytes, the β - angle conformation of SNAP-8 can be recognized by transport proteins on the cell membrane and enter the cytoplasm through endocytosis.
However, the barrier function of SC still significantly limits the delivery efficiency of SNAP-8. For example, without an auxiliary delivery system, the transdermal permeability of SNAP-8 is only 0.5%, far below the 5% threshold required for treatment.
Mucosal barrier: the "dynamic filter" of the mucus layer and the protein crown effect
The delivery of SNAP-8 in mucosal areas such as the respiratory and gastrointestinal tracts faces challenges from the mucus layer. Mucus is composed of mucin, lipids, and immunoglobulin, forming a dynamic "filter" structure with a pore size range of 10-1000 nm, which can intercept more than 90% of nanoparticles and peptide drugs.
The formation of mucus derived protein corona further complicates the delivery process. When SNAP-8 nanoparticles come into contact with mucus, mucin, immunoglobulin A (IgA), and complement proteins quickly adsorb onto the surface of the particles, forming a "hard crown" and a "soft crown".
Among them, the hard crown is composed of high affinity proteins, which form rapidly and stably; Soft crown is composed of low affinity proteins that are easy to dissociate. The composition and thickness of the protein crown directly affect the mucus penetration ability of nanoparticles.
Mucosal barrier: the "dynamic filter" of the mucus layer and the protein crown effect
The shielding effect of the hard crown: The mucin in the hard crown can bind to SNAP-8 through hydrogen bonding and hydrophobic interactions, forming a stable complex that prevents its interaction with target cells;
Dynamic regulation of soft crown: IgA and complement proteins in soft crown can release SNAP-8 through enzymatic hydrolysis or conformational changes, restoring its activity.
Experiments have shown that the diffusion coefficient of unmodified SNAP-8 nanoparticles in mucus is only 0.1 × 10 ⁻⁷ cm ²/s, while the diffusion coefficient of nanoparticles pre coated with mucin can be increased to 1.2 × 10 ⁻⁷ cm ²/s, indicating that the dynamic regulation of the protein crown is the key to breaking through the mucus barrier.
Cellular barrier: the "acid trap" of endosomes and lysosomal degradation
Even if SNAP-8 successfully penetrates the skin or mucosal barrier, it still needs to overcome intracellular delivery barriers. The endocytic lysosome pathway is the main way for cells to uptake exogenous substances, but the acidic environment (pH 4.5-5.0) and enzymatic hydrolysis of this pathway can significantly degrade SNAP-8. Research has shown that the half-life of SNAP-8 in endosomes is only 15 minutes, while in lysosomes it is shortened to 5 minutes. To improve delivery efficiency, it is necessary to achieve endocytic escape through the following strategies:
PH sensitive carrier: Nanoparticles prepared using polyethylene glycol polylactic acid hydroxyacetic acid copolymer (PEG-PLGA) can dissociate in an acidic environment of endosomes, releasing SNAP 8 Injection;
Membrane fusion peptide modification: covalently linking HA2 peptide (derived from influenza virus) with SNAP-8 can promote the fusion of nanoparticles with endocytic membranes, achieving content release;
Cell Penetrating Peptides (CPPs) Assist: Fusion of TAT peptide (from HIV-1) with SNAP-8 enhances its transmembrane transport capability, increasing cellular uptake rate by threefold.
Theoretical pathway of SNAP-8 autoimmune triggering: analysis based on molecular interactions and immune tolerance imbalance
In the field of biomedical science, the triggering mechanism of autoimmune diseases has long plagued researchers. In recent years, SNAP-8 (Acetyl Octapeptide-3), as a bioactive peptide with anti wrinkle function, has gradually revealed its molecular structure and functional mechanism. However, its potential association with autoimmune response has not been systematically explored.
Imbalance of immune tolerance: from antigen presentation to T cell activation
The triggering of autoimmune reactions requires breaking through the dual barriers of central and peripheral immune tolerance. SNAP-8 may disrupt immune tolerance through the following pathways:
During thymic development, T cells undergo negative selection to eliminate clones with high affinity for their own antigens. However, as an exogenous molecule, SNAP-8 may escape central tolerance through the following mechanisms:
Cross presentation: Although thymic medullary epithelial cells (mTECs) can express multiple tissue-specific antigens, they may not be able to encompass all potential self antigens. If the cross reactivity between SNAP-8 and SNAP-25 is not fully cleared, high affinity T cell clones may escape to the periphery.
The concealment of molecular simulation: The short peptide nature (8 amino acids) of SNAP-8 may make it difficult for it to be effectively presented by thymic stromal cells, resulting in T cells targeting its mimic epitope not being deleted.
In peripheral tissues, dendritic cells (DCs) and other APCs recognize pathogen associated molecular patterns (PAMPs) or injury associated molecular patterns (DAMPs) through pattern recognition receptors (PRRs). SNAP-8 may activate APC through the following ways:
Molecular simulation induced co stimulatory signals: The similarity between SNAP-8 and SNAP-25 may cause it to be mistaken by APCs as a "danger signal", triggering the upregulation of co stimulatory molecules (such as CD80/CD86) through Toll like receptors (TLRs) or NOD like receptors (NLRs), promoting T cell activation.
Abnormalities in antigen processing and presentation: SNAP-8 may be internalized by APCs and presented through MHC class II molecules, forming the "SNAP-8-MHC II" complex. If the complex binds to T cell clones that escape central tolerance, it can initiate the activation of self reactive T cells.
Activated T cells can differentiate into different subgroups, among which Th1 and Th17 are closely related to autoimmune diseases:
Th1 cells secrete pro-inflammatory cytokines such as IFN - γ and TNF - α, activate macrophages, and mediate tissue damage. If SNAP-8-induced T cells polarize towards Th1, it may trigger an inflammatory response similar to rheumatoid arthritis.
Th17 cells: secrete cytokines such as IL-17A and IL-22, promote neutrophil infiltration, and are associated with autoimmune diseases such as psoriasis and multiple sclerosis. SNAP-8 may drive Th17 differentiation through signaling pathways such as IL-6 and TGF - β.
B Cell Abnormal Activation and Autoantibody Production
In addition to T cell-mediated immune disorders, SNAP-8 can also induce abnormal activation of B cells, leading to the production of autoantibodies, which further amplifies autoimmune responses and participates in tissue damage. As key effector cells of humoral immunity, B cells maintain peripheral tolerance under physiological conditions through mechanisms such as clonal deletion, clonal anergy, and regulatory B cell (Breg) suppression. SNAP-8 may break B cell tolerance through molecular simulation and T cell help, thereby triggering autoantibody production, specifically through the following mechanisms:
Molecular simulation-mediated B cell receptor (BCR) cross-activation: SNAP-25 is widely expressed in neural tissues and also exists in small amounts in peripheral non-neural tissues. The high sequence homology between SNAP-8 and the epitope of SNAP-25 enables SNAP-8 to cross-bind to BCRs that originally recognize SNAP-25. Under physiological conditions, B cells targeting SNAP-25 are in a state of anergy or clonal deletion to avoid autoimmunity. However, as an exogenous short peptide, SNAP-8 can bind to these B cells with low affinity, and cooperate with the pro-inflammatory microenvironment induced by abnormal APC activation (such as high levels of IL-6 and BAFF), thereby breaking B cell anergy and initiating clonal proliferation and differentiation.
T cell-dependent B cell activation: The activated self-reactive T cells (especially Th1 and Th17 cells mentioned above) can secrete a variety of pro-inflammatory cytokines and express CD40L, which binds to CD40 on the surface of B cells to form a key co-stimulatory signal. This signal, together with the antigen signal provided by SNAP-8, promotes the differentiation of B cells into plasma cells, which secrete autoantibodies. These autoantibodies not only recognize SNAP-8, but also cross-react with endogenous SNAP-25 due to molecular simulation, forming immune complexes. The deposition of immune complexes in tissues (such as neural tissues, joints, and kidneys) can trigger complement activation and inflammatory cell infiltration, further exacerbating tissue damage and promoting the progression of autoimmune diseases.
Impairment of Breg cell function: Breg cells are a subset of B cells with immune regulatory functions, which can inhibit the activation of T cells and B cells by secreting anti-inflammatory cytokines (such as IL-10 and TGF-β), thereby maintaining immune tolerance. Studies have shown that exogenous antigens can inhibit the proliferation and function of Breg cells. SNAP-8 may reduce the number and regulatory ability of Breg cells through the TLR-NF-κB signaling pathway, weaken the inhibitory effect on self-reactive T and B cells, and further break immune tolerance, creating favorable conditions for the occurrence of autoimmune reactions.
B cell activation and autoantibody production: from T-B collaboration to pathological injury
The activation of self reactive T cells can further drive B cells to produce high affinity autoantibodies, forming immune complex deposits and leading to tissue damage.
Abnormalities in T-B cell cooperation
Activated Th cells bind to CD40 on the surface of B cells through CD40L, providing a co stimulatory signal that promotes B cell proliferation, differentiation into plasma cells, and secretion of antibodies. SNAP-8 may facilitate this process through the following mechanisms:
Tfh cell assistance
Follicular helper T cells (Tfh) guide B cell affinity maturation in the germinal center. The abnormal activation of Tfh cells induced by SNAP-8 may lead to increased cross reactivity of B cells to SNAP-25 or related antigens.
Epitope diffusion
Initial autoantibodies may target the mimic epitope of SNAP-8, but as the immune response progresses, B cells can recognize other epitopes of SNAP-25, forming "epitope diffusion" and expanding the range of autoimmune attacks.
Pathological effects of autoantibodies
Autoantibodies targeting SNAP-25 may damage tissues through the following pathways:
Neuromuscular junction dysfunction
SNAP-25 is a key protein for synaptic vesicle fusion, and autoantibody binding may block acetylcholine release, leading to muscle weakness or nerve conduction disorders, similar to the pathogenesis of myasthenia gravis (MG).
Central nervous system damage
If autoantibodies penetrate the blood-brain barrier, they may interfere with synaptic transmission between neurons, leading to neurodegenerative disorders such as demyelination damage in multiple sclerosis (MS).
Immune complex deposition
The complex formed by autoantibodies and antigens can deposit on the walls of blood vessels or tissue gaps, activate the complement system, recruit inflammatory cells, and lead to vasculitis or tissue necrosis.
FAQ
Can Snap 8 peptide be injected?
+
-
SNAP-8 is considered a safer and milder alternative to Botox because it does not require injections. Instead, it is formulated for topical application, making it a more accessible and pain-free option for individuals who want to achieve wrinkle-reducing effects without invasive procedures.
Is snap 8 better than Argireline?
+
-
The study shows that Snap 8 is approximately 30% more active than its parent peptide Argireline. Here's why: More amino acids : Snap 8 has 8 amino acids while Argireline has 6. Better results : Studies show Snap 8 reduces wrinkles more effectively.
Hot Tags: snap 8 injection, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale